Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Crispr Therapeutics AG (CRSP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Crispr Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
116.43 -4.82    -3.98%
24/09 - Closed. Currency in USD ( Disclaimer )
After Hours
116.33
-0.10
-0.09%
19:42:21 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  CH0334081137 
  • Volume: 1,083,089
  • Bid/Ask: 116.25 / 116.69
  • Day's Range: 116.01 - 120.24
Crispr Therapeutics 116.43 -4.82 -3.98%
Summary:Strong Sell
Moving Averages:Strong SellBuy (0)Sell (12)
Technical Indicators:Strong SellBuy (0)Sell (7)

Pivot PointsSep 25, 2021 07:05PM GMT

Name S3 S2 S1 Pivot Points R1 R2 R3
Classic 115.41 115.72 116.07 116.38 116.73 117.04 117.39
Fibonacci 115.72 115.97 116.13 116.38 116.63 116.79 117.04
Camarilla 116.24 116.30 116.36 116.38 116.48 116.54 116.60
Woodie's 115.43 115.73 116.09 116.39 116.75 117.05 117.41
DeMark's - - 116.22 116.46 116.89 - -

Technical IndicatorsSep 25, 2021 07:05PM GMT

Name Value Action
RSI(14) 43.358 Sell
STOCH(9,6) 12.769 Oversold
STOCHRSI(14) 2.489 Oversold
MACD(12,26) -0.310 Sell
ADX(14) 15.452 Neutral
Williams %R -93.548 Oversold
CCI(14) -109.1866 Sell
ATR(14) 1.5407 Less Volatility
Highs/Lows(14) -1.0871 Sell
Ultimate Oscillator 32.387 Sell
ROC -1.171 Sell
Bull/Bear Power(13) -2.3060 Sell

Buy: 0

Sell: 7

Neutral: 1


Summary:Strong Sell

Moving AveragesSep 25, 2021 07:05PM GMT

Period Simple Exponential
MA5 116.65
Sell
116.92
Sell
MA10 117.97
Sell
117.38
Sell
MA20 118.18
Sell
117.87
Sell
MA50 117.80
Sell
118.16
Sell
MA100 118.76
Sell
118.91
Sell
MA200 120.96
Sell
121.15
Sell

Buy: 0

Sell: 12


Summary:Strong Sell

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CRSP Comments

Write your thoughts about Crispr Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Fabrizio Lombardo
Fabrizio Lombardo Sep 16, 2021 10:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
97 usd  is a good entry point...
Nuno Da Silva
Nuno Da Silva Aug 30, 2021 1:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
a classic Cathy wood collapse
Jonathan badham
Jonathan badham Aug 17, 2021 7:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how do you actually buy shares i have a buy sell window open but its an ad i wanna actually buy a stock not be sent to yet another bs broker app
steve loeschke
steve loeschke Aug 17, 2021 7:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Check if you Bank can help you out
John Brand
John Brand Aug 17, 2021 7:15PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Open and fund a brokerage account. There are many options.
Barak David
Barak David Aug 02, 2021 3:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow
Ray Weber
Ray Weber Jul 29, 2021 5:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Beat on earnings!! Largly
kyle dvorsky
kyle dvorsky Jul 26, 2021 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Problem with this one is you're gonna need to wait a literal decade for it to be viable, regardless of studies/tests.
palmer gossett
palmer gossett Jul 26, 2021 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
true
Ray Weber
Ray Weber Jul 26, 2021 4:19PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think in a normal world… Definitely. My opinion, it right around the corner.
Nuno Da Silva
Nuno Da Silva Jul 26, 2021 1:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
total bubble of cathie wollod pump
도리 Dori
도리 Dori Jul 19, 2021 3:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
CRSP and AIRI are Good stockAIRI will go up to X3
palmer gossett
palmer gossett Jul 13, 2021 7:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
keep on dropping...
Nuno Da Silva
Nuno Da Silva Jul 08, 2021 9:15AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good entry point is around 80
palmer gossett
palmer gossett Jul 06, 2021 8:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
keep dropping, want to get back in
Ray Weber
Ray Weber Jul 05, 2021 6:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
206 by Oct
Adam Anderson
Adam Anderson Jul 05, 2021 6:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That would be acceptable.
Serdar Altinel
Serdar Altinel Jul 02, 2021 4:00AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Last weekend, Intellia Therapeutics and Regeneron announced first-ever clinical data that support the safety and efficacy of in vivo CRISPR genome editing in humans. We summarise the findings here.
Pro Investor
Pro Investor Jun 30, 2021 6:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ride it to new highs
Mayadachi Ikechi
Mayadachi Jun 28, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Alert: Crispr Therapeutics will acquire AGTC before end of FY2021 as a strategy to get into the ophthalmology space. Load up now & Stay tuned
palmer gossett
palmer gossett Jun 28, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ok, thanks
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 28, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thank you, but may we know your source, please?
Mary Miller
Mary Miller Jun 28, 2021 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What proof or source do you have that these facts have changed? See quote:  Gene therapy developer AGTC lost nearly half its market cap Thursday morning after Biogen exited a collaboration agreement on the heels of a big clinical failure. Interim six-month data on one of AGTC's investigational therapies showed it was generally safe but ineffective at treating a rare eye disorder known as X-linked retinoschisis (XLRS). The company plans to complete patient monitoring activities on the XLRS program but will not develop it further.
Neek Kajula
Neek Kajula Jun 28, 2021 7:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Held the dip, looks great
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 28, 2021 6:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i think that someone knew the news about intellia on friday already and then bought Crispr quickly.
Barak David
Barak David Jun 28, 2021 6:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i thought the same.. lucky enough it was good news
Adam Anderson
Adam Anderson Jun 28, 2021 4:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
ouch...shorts are about to get crushed
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 26, 2021 2:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It will most likely go higher on monday due to good results from Intellia.
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 24, 2021 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any reason why it's up over 5% today?
Terminal Velocity
Terminal Velocity Jun 24, 2021 11:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lander.gates.fauci
palmer gossett
palmer gossett Jun 15, 2021 9:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buying more around $100
Adam Anderson
Adam Anderson Jun 15, 2021 9:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Thank you for your insight...please take your seat now.
Adam Anderson
Adam Anderson Jun 11, 2021 8:30AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
short squeeze coming
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 11, 2021 8:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.businesswire.com/news/home/20210611005069/en/Vertex-and-CRISPR-Therapeutics-Present-New-Data-in-22-Patients-With-Greater-Than-3-Months-Follow-Up-Post-Treatment-With-Investigational-CRISPRCas9-Gene-Editing-Therapy-CTX001%E2%84%A2-at-European-Hematology-Association-Annual-Meeting
Rajesh Kumar
Rajesh Kumar Jun 08, 2021 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good n3ws is coming . About to breakout to $130
palmer gossett
palmer gossett Jun 08, 2021 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what news
Rajesh Kumar
Rajesh Kumar Jun 08, 2021 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There are two health care conferences on Jun 8 and Jun 11. I am expecting good news about crsp from both conferences.
Andrew Kittle
Andrew Kittle Jun 08, 2021 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ongoing CLIMB SCD-121 Study of Autologous Crispr-Cas9-Modified CD34+ Hematopoietic Stem and Progenitor Cells,” will be made available on the virtual platform as an e-poster Friday, June 11 at
Bryan The Crystal Ball
Bryan The Crystal Ball Jun 08, 2021 10:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Well done, Rajesh Kumar!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email